Source: South China Morning PostThe World Health Organization’s review of two Chinese Covid-19 vaccines for emergency use licensing – a prerequisite for their inclusion in the Covax Facility global vaccine distribution programme – is proceeding as scheduled. Kate O’Brien, director of the WHO’s immunisation department, said on Thursday meetings to discuss Sinopharm and Sinovac were planned for Monday and May 3, respectively. “We are pleased that we are at a point that these review meetings can be scheduled and we are looking…Read More